The Evolving Landscape of Checkpoint Inhibitor Combination Therapy in the Treatment of Advanced Hepatocellular Carcinoma

Liu, L; Qin, SK; Zhang, Y

Qin, SK (corresponding author), Nanjing Chinese Med Univ, Jinling Hosp, Canc Ctr, Nanjing 210002, Peoples R China.; Zhang, Y (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Jiangsu Key Lab Biomat & Devices, Nanjing 210009, Peoples R China.

TARGETED ONCOLOGY, 2021; 16 (2): 153

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers and a main cause of cancer-associated death worldwide. Even with the successful launc......

Full Text Link